RESHAPE LIFESCIENCES INC.: 10-Q filed 2011-11-04

Name: RESHAPE LIFESCIENCES INC.: 10-Q filed 2011-11-04
Creator: RESHAPE LIFESCIENCES INC.

What RESHAPE LIFESCIENCES INC. reported in its quarterly report filed 2011-11-04 (fiscal Q3 2011): 27 published measures, 77 facts as tagged in accession 0001193125-11-296900.

This filing

Form: 10-Q (quarterly report)
Filed: 2011-11-04
Fiscal period: fiscal Q3 2011
Accession: 0001193125-11-296900 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All RESHAPE LIFESCIENCES INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-09-30	36,997,884	USD
At 2010-12-31	38,687,265	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2011-09-30	9,732,402	USD
At 2010-12-31	8,980,208	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-09-30	27,265,482	USD
At 2010-12-31	29,707,057	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-09-30	32,438,627	USD
At 2010-12-31	30,840,560	USD
At 2010-09-30	12,553,884	USD
At 2009-12-31	14,617,594	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-7,298,112	USD	92
2011-01-01 to 2011-09-30	-17,941,235	USD	273
2002-12-19 to 2011-09-30	-168,525,254	USD	3208
2010-07-01 to 2010-09-30	-4,385,371	USD	92
2010-01-01 to 2010-09-30	-13,392,431	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	-14,522,528	USD	273
2002-12-19 to 2011-09-30	-141,770,251	USD	3208
2010-01-01 to 2010-09-30	-10,128,697	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	239,044	USD	273
2002-12-19 to 2011-09-30	2,817,992	USD	3208
2010-01-01 to 2010-09-30	2,592	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	13,040,588	USD	273
2002-12-19 to 2011-09-30	179,926,799	USD	3208
2010-01-01 to 2010-09-30	8,067,579	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	3,080,007	USD	273
2002-12-19 to 2011-09-30	-5,717,921	USD	3208
2010-01-01 to 2010-09-30	-2,592	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-09-30	-168,656,222	USD
At 2010-12-31	-150,714,987	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-09-30	568,267	USD
At 2010-12-31	741,564	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	2,092,058	USD	273
2002-12-19 to 2011-09-30	13,662,528	USD	3208
2010-01-01 to 2010-09-30	2,178,259	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-09-30	36,361,388	USD
At 2010-12-31	37,804,129	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-09-30	6,307,372	USD
At 2010-12-31	3,997,049	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-09-30	261,315	USD
At 2010-12-31	125,188	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	7,133,468	USD	92
2011-01-01 to 2011-09-30	17,371,133	USD	273
2002-12-19 to 2011-09-30	157,065,092	USD	3208
2010-07-01 to 2010-09-30	4,094,192	USD	92
2010-01-01 to 2010-09-30	12,557,434	USD	273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	2,354,501	USD	92
2011-01-01 to 2011-09-30	6,488,749	USD	273
2002-12-19 to 2011-09-30	46,074,372	USD	3208
2010-07-01 to 2010-09-30	1,751,870	USD	92
2010-01-01 to 2010-09-30	5,496,247	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	4,778,967	USD	92
2011-01-01 to 2011-09-30	10,882,384	USD	273
2002-12-19 to 2011-09-30	110,990,720	USD	3208
2010-07-01 to 2010-09-30	2,342,322	USD	92
2010-01-01 to 2010-09-30	7,061,187	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-09-30	36,748,281	shares
At 2010-12-31	27,892,388	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-09-30	195,554,395	USD
At 2010-12-31	180,143,120	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2011-09-30	-174	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2011-09-30	68,229	USD
At 2010-12-31	141,572	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2011-09-30	3,340,035	USD
At 2010-12-31	2,538,371	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2011-09-30	716,363	USD
At 2010-12-31	436,538	USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	223,590	USD	273
2002-12-19 to 2011-09-30	2,179,656	USD	3208
2010-01-01 to 2010-09-30	286,364	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	847	USD	92
2011-01-01 to 2011-09-30	-17,080	USD	273
2002-12-19 to 2011-09-30	-250,629	USD	3208
2010-07-01 to 2010-09-30	-4,689	USD	92
2010-01-01 to 2010-09-30	-19,950	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	323,609	USD	273
2002-12-19 to 2011-09-30	257,258	USD	3208
2010-01-01 to 2010-09-30	48,530	USD	273

Inspect the source

Entity: RESHAPE LIFESCIENCES INC. / CIK 0001371217
Captured: 2026-09-22 19:45 UTC
SEC response SHA-256: 342900799b6d8ad7d662fb719941027b7ec7f1c6df6a2cd8acf7226229080bfa

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001371217.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))